Skip to content

dmplusOn July 1, DynaMed interface will be updated with a sleeker look and improved functionality.  The new interface is called DynaMed Plus and includes:

  • Overviews and Recommendations provide concise, accurate overviews for the most common conditions as well as evidence-based recommendations for action.
  • Micromedex® Clinical Knowledge Suite drug content includes medication management and lab recommendations, including IV screening, medication advisory screening and summary drug information.
  • Graphics and Images comprise more than 2,500 medical graphics and images with over 1000 images from the American College of Physicians.
  • Improved search results are due to a redesign from the ground up, focused on time-to-answer for the busy clinician.
  • Mobile-Optimized Access provides interface customized to the screen size of your phone or mobile device.

Alongside, DynaMed Plus’s improved interface, users can still rely on DynaMed’s core features including:

  • Daily Updates - New evidence is added to DynaMed Plus multiple times each day, ensuring you always have the most current information.
  • Expert Reviewers - subject-specific experts who review topics using the DynaMed Plus proprietary 7 Step EBM Process and the 9-Step Quality Process for creating content.
  • Specialty Content - a wide array of specialty topics in areas such as infectious disease and immunology, cardiology, oncology and emergency medicine.
  • DynaMed Plus App - Users can install DynaMed Plus content to their phone or handheld device to have guaranteed access to DynaMed’s evidence-based content even in areas without phone or wifi service.

medications-342484_960_720The challenges and promise of drugs which work (or don't) based on a patient's genetic make-up is is discussed in an article recently published in the New England Journal of Medicine.   GW faculty Shawneequa Callier and her co-authors describe the market forces and recent litigation which is shaping personalized medicine in this article:
Bonham, V. L., Callier, S. L., & Royal, C. D. (2016). Will Precision Medicine Move Us beyond Race?. The New England journal of medicine, 374(21), 2003.
You can read the full-text article as part of Himmelfarb Library's online collection and find this article and additional publications in the Dr. Charles Macri's Genetics Journal Club.

GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the Accessibility Feedback Form.